Overcoming original antigenic sin to generate new CD8 T cell IFN-gamma responses in an antigen-experienced host

J Immunol. 2006 Sep 1;177(5):2873-9. doi: 10.4049/jimmunol.177.5.2873.

Abstract

The failure to mount effective immunity to virus variants in a previously virus-infected host is known as original antigenic sin. We have previously shown that prior immunity to a virus capsid protein inhibits induction by immunization of an IFN-gamma CD8+ T cell response to an epitope linked to the capsid protein. We now demonstrate that capsid protein-primed CD4+ T cells secrete IL-10 in response to capsid protein presented by dendritic cells, and deviate CD8+ T cells responding to a linked MHC class I-restricted epitope to reduce IFN-gamma production. Neutralizing IL-10 while delivering further linked epitope, either in vitro or in vivo, restores induction by immunization of an Ag-specific IFN-gamma response to the epitope. This finding demonstrates a strategy for overcoming inhibition of MHC class I epitopes upon immunization of a host already primed to Ag, which may facilitate immunotherapy for chronic viral infection or cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / metabolism
  • CD8-Positive T-Lymphocytes / immunology*
  • Cell Communication
  • Cells, Cultured
  • DNA / immunology
  • Dendritic Cells / immunology
  • Female
  • Immunization
  • Interferon-gamma / immunology*
  • Interferon-gamma / metabolism
  • Interleukin-10 / immunology
  • Mice
  • Mice, Inbred C57BL
  • Oligodeoxyribonucleotides
  • Oncogene Proteins, Viral / immunology*
  • Papillomavirus E7 Proteins
  • Receptors, Interleukin / immunology
  • Receptors, Interleukin-10
  • Receptors, Interleukin-2 / immunology
  • Spodoptera

Substances

  • CpG ODN 1826
  • Oligodeoxyribonucleotides
  • Oncogene Proteins, Viral
  • Papillomavirus E7 Proteins
  • Receptors, Interleukin
  • Receptors, Interleukin-10
  • Receptors, Interleukin-2
  • oncogene protein E7, Human papillomavirus type 16
  • Interleukin-10
  • Interferon-gamma
  • DNA